1. Latest News
  2. Submit Press Release

BCRX Recommended As Biotech Stock Of The Week By STW Analyst

BioCryst Pharmaceuticals-BCRX is the www.Stocktipweekly.com biotech-pharmaceutical stock of the week based on technical analysis and expected positive trial news.

PRLog - Sep. 1, 2010 - ORLANDO, Fla. -- BCRX is an emerging biotech–pharmaceutical stock with several promising drugs in the pipeline. It is hard to say which of BioCryst Pharmaceuticals 3 drugs will be the first or best candidate to generously reward stockholders. With Trial results from 2 leading candidates expected to be released in the next few months and flu season around the corner stockholders of BCRX are entering an exciting and potentially very profitable time.For an in depth report on BCRX stock visit http://www.stocktipweekly.com where stock market traders and investors benefit from the research and experience of the STW analysts.

# # #

The stock analysts at STW isolate emerging & small cap stocks focusing on the biotech and pharmaceutical sectors. Each week they feature one stock recommendation that analysis shows has good upside potential for a swing trade or long term profits. The STW stock picks are chosen on several factors including current company news, FDA trials, technical analysis and general market trends to help traders and investors select the best share price entry and timing. Always do your own their own due diligence before deciding to take a position in any investment.

--- End ---

Click to Share

Contact Email:
***@stocktipweekly.com Email Verified
Source:Mark Geallis
Location:Orlando - Florida - United States
Industry:Health, Medical, Finance
Tags:bcrx stock, biotech stocks, investments, pharmaceutical, penny stocks, stock trading, flu, gout, cancer
Verified Account Email Address

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Trending News...

Like PRLog?
Click to Share